Biomarkers of response to neoadjuvant endocrine therapy with anastrozole (Ana) alone or in combination with fulvestrant (Ful) in ER-positive (ER+) HER2-negative (HER2-) breast cancer (PACT01 trial)

被引：0
|
作者：
Dhamne, S.
Nagi, C.
Wang, T.
Pavlick, A. C.
Reusser, B.
Schiff, R.
Julie, N.
Niravath, P.
Silberfein, E. J.
Sedgwick, E. L.
Sepulveda, K. A.
Gutierrez, C.
Hilsenbeck, S. G.
Chang, J. C.
Osborne, C. K.
Rimawi, M. F.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Houston Methodist Hosp, Houston, TX USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P4-15-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-15-05
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer
    Ueno, Takayuki
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [2] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [3] Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer
    Matikas, Alexios
    Foukakis, Theodoros
    Michalakis, Ilias
    Georgoulias, Vassilis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 319 - 326
  • [4] Novel Endocrine Therapy Agents in ER-Positive, HER2-Negative Breast Cancer
    Hamilton, Erika P.
    Rugo, Hope S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (03) : 125 - 127
  • [5] New Approaches to Endocrine Therapy in ER-Positive, HER2-Negative Breast Cancer
    Hamilton, Erika P.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (06) : 356 - 358
  • [6] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    da Silva, Leonardo Roberto
    de Andrade, Camila Annicchino
    Brenelli, Fabricio
    Ramalho, Susana
    Reinert, Tomas
    de Souza, Alessandra Borba Anton
    da Silva, Ana Elisa Ribeiro
    de Paula Leite Kraft, Maria Beatriz
    de Vasconcelos, Vivian Castro Antunes
    Frasson, Antonio Luiz
    Torresan, Renato Zochio
    Cabello, Cesar
    Ellis, Matthew J.
    Zeferino, Luiz Carlos
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 753 - 760
  • [7] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    Leonardo Roberto da Silva
    Camila Annicchino de Andrade
    Fabrício Brenelli
    Susana Ramalho
    Tomás Reinert
    Alessandra Borba Anton de Souza
    Ana Elisa Ribeiro da Silva
    Maria Beatriz de Paula Leite Kraft
    Vivian Castro Antunes de Vasconcelos
    Antônio Luiz Frasson
    Renato Zochio Torresan
    Cesar Cabello
    Matthew J. Ellis
    Luiz Carlos Zeferino
    Breast Cancer Research and Treatment, 2021, 186 : 753 - 760
  • [8] Axillary Response to Neoadjuvant Therapy in Node-Positive ER-Positive, HER2-Negative Breast Cancer
    Friedman-Eldar, Orli
    Ozmen, Tolga
    Reyes, Fernando Valle
    Goel, Neha
    Tjendra, Youley
    Kesmodel, Susane B.
    Moller, Mecker
    Franceschi, Dido
    Avisar, Eli
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S236 - S236
  • [9] The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer
    Fjermeros, Kamilla
    Ghannoum, Salim
    Geisler, Stephanie B.
    Bhargava, Sameer
    Tahiri, Andliena
    Klajic, Jovana
    Luders, Torben
    Fongard, Marie
    Nawaz, Meh Sameen
    Bosnjak-Olsen, Tatjana
    Buvarp, Unn-Cathrin Edvardsen
    Johanna Rosenskiold, Aino Katri
    Nguyen, Nam Thi
    Sletbak, Tone Tysko
    Seyedzadeh, Manouchehr
    Selsas, Knut
    Porojnicu, Alina Carmen
    Skjerven, Helle Kristine
    Hovda, Tone
    Sahlberg, Kristine Kleivi
    Torland, Lilly Anne
    Lyngra, Marianne
    Hammarstrom, Clara Louise
    Honigsperger, Elma Bahonjic
    Noone, John Christopher
    Mathiassen, Silje
    Hurtado, Antoni
    Goel, Shom
    Koff, Andrew
    Tekpli, Xavier
    Kristensen, Vessela N.
    Geisler, Juergen
    FUTURE ONCOLOGY, 2024,
  • [10] Endo Predict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer
    Bertucci, Francois
    Finetti, Pascal
    Viens, Patrice
    Birnbaum, Daniel
    CANCER LETTERS, 2014, 355 (01) : 70 - 75
12345